125 related articles for article (PubMed ID: 31700039)
1. The beneficial effects of a muscarinic agonist on pancreatic β-cells.
Ito Y; Kaji M; Sakamoto E; Terauchi Y
Sci Rep; 2019 Nov; 9(1):16180. PubMed ID: 31700039
[TBL] [Abstract][Full Text] [Related]
2. Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus.
Chowdhury S; Wang S; Dunai J; Kilpatrick R; Oestricker LZ; Wallendorf MJ; Patterson BW; Reeds DN; Wice BM
PLoS One; 2016; 11(6):e0156852. PubMed ID: 27304975
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 and candesartan additively improve glucolipotoxicity in pancreatic β-cells.
Wang HW; Mizuta M; Saitoh Y; Noma K; Ueno H; Nakazato M
Metabolism; 2011 Aug; 60(8):1081-9. PubMed ID: 21255808
[TBL] [Abstract][Full Text] [Related]
4. GLP-1 receptor agonist liraglutide exerts central action to induce β-cell proliferation through medulla to vagal pathway in mice.
Kumari P; Nakata M; Zhang BY; Otgon-Uul Z; Yada T
Biochem Biophys Res Commun; 2018 May; 499(3):618-625. PubMed ID: 29601817
[TBL] [Abstract][Full Text] [Related]
5. Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis.
Kapodistria K; Tsilibary EP; Kotsopoulou E; Moustardas P; Kitsiou P
J Cell Mol Med; 2018 Jun; 22(6):2970-2980. PubMed ID: 29524296
[TBL] [Abstract][Full Text] [Related]
6. Role of the M3 muscarinic acetylcholine receptor in beta-cell function and glucose homeostasis.
Gautam D; Han SJ; Duttaroy A; Mears D; Hamdan FF; Li JH; Cui Y; Jeon J; Wess J
Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():158-69. PubMed ID: 17919190
[TBL] [Abstract][Full Text] [Related]
7. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.
Wei Q; Sun YQ; Zhang J
Peptides; 2012 Sep; 37(1):18-24. PubMed ID: 22776329
[TBL] [Abstract][Full Text] [Related]
8. The role of glucokinase and insulin receptor substrate-2 in the proliferation of pancreatic beta cells induced by short-term high-fat diet feeding in mice.
Kitao N; Nakamura A; Miyoshi H; Nomoto H; Takahashi K; Omori K; Yamamoto K; Cho KY; Terauchi Y; Atsumi T
Metabolism; 2018 Aug; 85():48-58. PubMed ID: 29544862
[TBL] [Abstract][Full Text] [Related]
9. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
Lee YS; Jun HS
Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-Like Peptide 1 Increases β-Cell Regeneration by Promoting α- to β-Cell Transdifferentiation.
Lee YS; Lee C; Choung JS; Jung HS; Jun HS
Diabetes; 2018 Dec; 67(12):2601-2614. PubMed ID: 30257975
[TBL] [Abstract][Full Text] [Related]
11. Requirement of NF-kappaB signalling pathway for modulation of the cholinergic muscarinic M3 receptor expression by INGAP-PP in insulin-producing cells.
Paula FM; Barbosa HC; Carneiro EM; Persaud SJ; Gagliardino JJ; Boschero AC; Souza KL
Eur J Pharmacol; 2010 Sep; 642(1-3):37-46. PubMed ID: 20541544
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic muscarinic receptor activation augments murine intestinal epithelial cell proliferation and tumorigenesis.
Peng Z; Heath J; Drachenberg C; Raufman JP; Xie G
BMC Cancer; 2013 Apr; 13():204. PubMed ID: 23617763
[TBL] [Abstract][Full Text] [Related]
13. Impact of the dipeptidyl peptidase-4 inhibitor vildagliptin on glucose tolerance and β-cell function and mass in insulin receptor substrate-2-knockout mice fed a high-fat diet.
Sato K; Nakamura A; Shirakawa J; Muraoka T; Togashi Y; Shinoda K; Orime K; Kubota N; Kadowaki T; Terauchi Y
Endocrinology; 2012 Mar; 153(3):1093-102. PubMed ID: 22315446
[TBL] [Abstract][Full Text] [Related]
14. GLP-1 signalling compensates for impaired insulin signalling in regulating beta cell proliferation in βIRKO mice.
Kawamori D; Shirakawa J; Liew CW; Hu J; Morioka T; Duttaroy A; Burkey B; Kulkarni RN
Diabetologia; 2017 Aug; 60(8):1442-1453. PubMed ID: 28526921
[TBL] [Abstract][Full Text] [Related]
15. β-Cell proliferation after a partial pancreatectomy is independent of IRS-2 in mice.
Togashi Y; Shirakawa J; Orime K; Kaji M; Sakamoto E; Tajima K; Inoue H; Nakamura A; Tochino Y; Goshima Y; Shimomura I; Terauchi Y
Endocrinology; 2014 May; 155(5):1643-52. PubMed ID: 24517226
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response.
Natalicchio A; Biondi G; Marrano N; Labarbuta R; Tortosa F; Spagnuolo R; D'Oria R; Carchia E; Leonardini A; Cignarelli A; Perrini S; Laviola L; Giorgino F
Endocrinology; 2016 Jun; 157(6):2243-58. PubMed ID: 27035653
[TBL] [Abstract][Full Text] [Related]
17. A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo.
Gautam D; Han SJ; Hamdan FF; Jeon J; Li B; Li JH; Cui Y; Mears D; Lu H; Deng C; Heard T; Wess J
Cell Metab; 2006 Jun; 3(6):449-61. PubMed ID: 16753580
[TBL] [Abstract][Full Text] [Related]
18. RGS4 is a negative regulator of insulin release from pancreatic beta-cells in vitro and in vivo.
Ruiz de Azua I; Scarselli M; Rosemond E; Gautam D; Jou W; Gavrilova O; Ebert PJ; Levitt P; Wess J
Proc Natl Acad Sci U S A; 2010 Apr; 107(17):7999-8004. PubMed ID: 20385802
[TBL] [Abstract][Full Text] [Related]
19. Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome.
Kondo M; Tanabe K; Amo-Shiinoki K; Hatanaka M; Morii T; Takahashi H; Seino S; Yamada Y; Tanizawa Y
Diabetologia; 2018 Oct; 61(10):2189-2201. PubMed ID: 30054673
[TBL] [Abstract][Full Text] [Related]
20. IPP-1 controls Akt/CREB phosphorylation extension in A
Shahrestanaki MK; Arasi FP; Aghaei M
Eur J Pharmacol; 2019 May; 850():88-96. PubMed ID: 30772395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
